Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bioiberica

Criteria

Inclusion Criteria:

• Primary knee OA according to ACR criteria;

• OA of radiological stages 1 to 3 according to Kellgren-Lawrence;

• VAS of pain ≥30;

• PASI ≥ 5.

Exclusion Criteria:

• Known allergy to chondroitin sulphate;

• Other bone and articular diseases such as chondrocalcinosis, Paget's disease, rheumatoid arthritis, psoriatic arthritis, acromegaly, hemochromatosis, Wilson's disease;

• Patients with skin conditions that could interfere in the clinical trial evaluation